Announcement

Collapse
No announcement yet.

J Med Virol . The immunodominance of RBD antigen of delta variant as vaccine candidate against SARS-CoV-2 infection

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • J Med Virol . The immunodominance of RBD antigen of delta variant as vaccine candidate against SARS-CoV-2 infection


    J Med Virol


    . 2022 Nov 29.
    doi: 10.1002/jmv.28359. Online ahead of print.
    The immunodominance of RBD antigen of delta variant as vaccine candidate against SARS-CoV-2 infection


    Deyan Luo 1 , Tao Li 1 , Xiaolan Yang 1 , Nianzhi Ning 1 , Liangyan Zhang 1 , Hongjing Gu 1 , Deyu Li 1 , Wenjing Yu 1 , Zhongyu Hu 2 , Hui Wang 1



    Affiliations

    Abstract

    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel subset of coronavirus that causes coronavirus disease 2019 (COVID-19), but vaccine development is hampered by the high mutation of virus This article is protected by copyright. All rights reserved.

    Keywords: Disease control; Immune responses; SARS coronavirus; Vaccines/Vaccine strains; Virus classification.

Working...
X